According to the Zhitong Finance App, Xianjian Technology (01302) announced the results for the year ended December 31, 2023. The group obtained revenue of RMB 1,267 billion (same unit), an increase of 15.48% over the previous year; profit attributable to the company owners was 263 million yuan, a decrease of 19.09% over the previous year; and the basic profit per share was 6 points.

According to the announcement, the increase in revenue was mainly due to increased revenue from sales of congenital heart disease occulators and laminated stents.